The use of bevacizumab in pediatric retinal and choroidal disease: A review

Peter J. Belin, Andrew C. Lee, Giovanni Greaves, Jennifer Kosoy, Ronni M. Lieberman

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.

Original languageEnglish (US)
Pages (from-to)338-347
Number of pages10
JournalEuropean Journal of Ophthalmology
Volume29
Issue number3
DOIs
StatePublished - May 1 2019

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Fingerprint

Dive into the research topics of 'The use of bevacizumab in pediatric retinal and choroidal disease: A review'. Together they form a unique fingerprint.

Cite this